Tulane researchers developed a rapid CRISPR-based blood test for Nontuberculous Mycobacteria infections, accurately diagnosing over 93% of cases in two hours.
Tulane University researchers have developed a rapid CRISPR-based blood test that diagnoses Nontuberculous Mycobacteria (NTM) infections in two hours, compared to months with traditional methods. The test, which accurately identifies over 93% of patients with NTM infection, is designed to detect Mycobacterium avium complex (MAC), the most common type and leading cause of NTM-induced pulmonary disease. The test detects NTM DNA fragments in the bloodstream, enabling faster diagnosis and potentially reducing barriers to testing in the face of rising NTM infections.
March 14, 2024
4 Articles